![[Image: masthead]](/mhau001/includes/themes/MHAUS_2016/images/masthead/masthead-large.png)
Outside NA: 001-209-417-3722
FOR EMERGENCIES ONLY
MHAUS Recommendations
MHAUS does not intend for these recommendations to be standards, guidelines, practice parameters, or clinical requirements nor does application of these recommendations guarantee any specific outcome. Furthermore, these recommendations may be adopted, modified, or rejected according to clinical needs and restraints. MHAUS recognizes that these recommendations are subject to revision as warranted by the evolution of medical knowledge, technology, and practice. Additionally, individual MH consultant opinion may vary and variability of opinion of different responses based on given clinical situation.
Click to download/print/view
Table of Contents followed by completed
On topics that we are frequently asked for guidance, the following evidence-based recommendations have been developed for use in the healthcare community:
Click to read about The MHAUS Recommendation Development Process
-
- Masseter Muscle Rigidity: Definition, Relationship to Malignant Hyperthermia, and Management
-
Posted in 2018
Recommendations and supporting evidence.
-
- What evidence-based interventions are recommended to alleviate hyperthermia associated with Malignant Hyperthermia?
-
Posted in 2018
Recommendations and supporting evidence.
-
- Can Patients with a Suspected Personal or Family History of MH be Safely Anesthetized Prior to Diagnostic Testing for MH Susceptibility
-
Posted in 2018
Recommendations and supporting evidence.
-
- How Much Dantrolene Should be Available in Facilities Where Volatile Agents are not Available or Administered, and Succinylcholine is Only Stocked on Site for Emergency Purposes?
-
Posted in 2018
Recommendations and supporting evidence.
-
- Relationship Between MH Susceptibility and Heat or Exercise Related Rhabdomyolysis
-
Posted in 2017
Recommendations and supporting evidence.
-
- Dantrolene Administration After an MH Event
-
Posted in 2017
Recommendations and supporting evidence.
-
- Does Noonan Syndrome Increase Malignant Hyperthermia Susceptibility?
-
Posted in 2012
Recommendations and supporting evidence.
-
- Adverse Effects of Heat and Exercise in Relation to MH Susceptibility
-
Posted in 2012
Recommendations and supporting evidence.
-
- Does Mitochondrial Myopathy (MM) Increase an Individual's Susceptibility to Malignant Hyperthermia (MH)?
-
Posted in 2012
Recommendations and supporting evidence.
-
- MH-Susceptibility and Operating Room Personnel: Defining the Risks
-
Posted in 2012
The contraindications for the administration of succinylcholine and the potent volatile inhalational anesthetics to Malignant Hyperthermia Susceptible (MHS) individuals are well documented and defined. However, there are no published data on risks to these individuals associated with environmental exposure to waste gases in the operating room.
-
- Parturient with MHS Partner
-
Posted in 2012
Suggested Guidelines for management of the Pregnant-patient not believed to be at risk for MH, but WHOSE PARTNER is susceptible to malignant hyperthermia.
-
- Preparation of Anesthesia Workstations to Anesthetize MH Susceptible Patients
-
Posted in 2012
Recommendations for the preparation of anesthesia workstations to anesthetize MH susceptible patients.
-
- Temperature Monitoring during Surgical Procedures
-
Posted in 2012
MHAUS recommends core temperature monitoring for all patients given general anesthesia lasting more than 30 minutes. Appropriate sites for continuous electronic core temperature monitoring include the esophagus, nasopharynx, tympanic membrane (with probe in contact with the membrane), bladder, and the pulmonary artery.
-
- The MHAUS Recommendation Development Process
-
The MHAUS Recommendation Development Process